Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to -$2.4 million.

  • Quipt Home Medical's Net Cash Flow fell 198153.85% to -$2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.6 million, marking a year-over-year decrease of 25724.74%. This contributed to the annual value of -$3.0 million for FY2025, which is 17905.47% down from last year.
  • Per Quipt Home Medical's latest filing, its Net Cash Flow stood at -$2.4 million for Q4 2025, which was down 198153.85% from $1.7 million recorded in Q3 2025.
  • In the past 5 years, Quipt Home Medical's Net Cash Flow ranged from a high of $4.1 million in Q2 2024 and a low of -$12.6 million during Q1 2022
  • Over the past 5 years, Quipt Home Medical's median Net Cash Flow value was -$2000.0 (recorded in 2021), while the average stood at -$1.1 million.
  • Data for Quipt Home Medical's Net Cash Flow shows a peak YoY increase of 17413.95% (in 2025) and a maximum YoY decrease of 198153.85% (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Quipt Home Medical's Net Cash Flow stood at -$4.5 million in 2021, then fell by 7.03% to -$4.9 million in 2022, then surged by 116.78% to $815000.0 in 2023, then tumbled by 84.05% to $130000.0 in 2024, then tumbled by 1981.54% to -$2.4 million in 2025.
  • Its Net Cash Flow was -$2.4 million in Q4 2025, compared to $1.7 million in Q3 2025 and -$6.5 million in Q2 2025.